Salesforce's $15 billion commitment signals the start of a massive enterprise AI transformation. Companies across the value chain are positioned to benefit from this unprecedented investment wave.
Agentforce 360 represents the future of work where humans collaborate with AI agents. This shift creates demand for the entire technology stack powering these intelligent systems.
From semiconductors to cloud platforms, the companies building AI's foundation are experiencing surging demand as enterprise adoption accelerates across industries.
Market capitalisation breakdown for the 'Salesforce's AI Agent Revolution' basket.
CRM: $236.81B
NVDA: $4.58T
SNOW: $83.78B
Salesforce's $15 billion investment in Agentforce 360 represents a pivotal shift towards agentic AI, where humans collaborate directly with AI systems. This massive enterprise push creates opportunities across the entire AI value chain, from foundational models to specialized infrastructure that powers these sophisticated platforms.
This collection focuses on the broad ecosystem required to support large-scale enterprise AI adoption. It includes companies involved in AI models, data management, cloud computing, and the specialized semiconductors that form the backbone of AI infrastructure, offering diversified exposure to this technological shift.
These companies were handpicked by professional analysts as key technology providers and infrastructure players positioned to benefit from the rising tide of enterprise AI adoption. Each represents a different piece of the puzzle needed to power Salesforce's AI revolution and similar initiatives across industries.
Salesforce has launched Agentforce 360, a new platform for AI-human collaboration, backed by a $15 billion investment to expand its AI innovation. This move creates a significant investment opportunity in the ecosystem of AI technology providers and infrastructure companies that power this new wave of enterprise AI.
์ด ๋ฐ์ค์ผ์ ์ ์ฒด ์คํ ๋ฆฌ๋ฅผ ํ์ธํ์ธ์. ๋ฆฌ์คํฌ์ ์ ์ฌ๋ ฅ์ ๋ค๋ฃฌ ์์ธ ๊ธฐ์ฌ๋ฅผ ์ฝ์ด๋ณด์ธ์.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
Earn 6% AER on uninvested cash with daily interest payments.
10์ 14 ๊ฒ์
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+7
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
์ด ์์ฐ๋ค์ ํฌ์ํ๋ค๋ฉด:
12๊ฐ์ ํ ์์ ๊ฐ์น:
+59.08%
์ ๋๋ฆฌ์คํธ๋ค์ ์ด ๊ทธ๋ฃน์ ์์ฐ์ด ํฅํ 1๋ ๊ฐ ํ๊ท 59.08% ์ฑ์ฅํ ๊ฒ์ผ๋ก ์์ํฉ๋๋ค.
์ด ๊ทธ๋ฃน์ ์์ฐ 17๊ฐ ์ค 11๊ฐ๊ฐ ์ ๋ฌธ ์ ๋๋ฆฌ์คํธ๋ก๋ถํฐ ๋งค์ ์๊ฒฌ์ ๋ฐ์์ต๋๋ค.
